-
Opiant Pharmaceuticals Inc (NASDAQ: OPNT) shares
tumbled 23.4 percent to $37.90.
-
Advaxis, Inc. (NASDAQ: ADXS) shares fell 18.4
percent to $5.57. Advaxis reported a Q3 loss of $32.6 million.
-
Health Insurance Innovations Inc (NASDAQ: HIIQ)
shares declined 18.1 percent to $19.13 after dropping 21.91 percent on Monday.
-
SAGE Therapeutics Inc. (NASDAQ: SAGE) shares
dropped 17.5 percent to $72.99 after the company disclosed that its Phase 3 STATUS trial of brexalonone in super-refractory
status epilepticus did not meet its primary endpoint.
-
Intercept Pharmaceuticals Inc (NASDAQ: ICPT)
shares declined 15.2 percent to $96.29.
-
JMU Ltd- ADR (NASDAQ: JMU) shares fell 9 percent
to $1.82
-
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX)
dropped 8.4 percent to $5.27 as the company reported a $80 million offering of common stock.
-
Limoneira Company (NASDAQ: LMNR) declined 7.7
percent to $22.50. Limoneira reported Q3 earnings of $0.52 per share on revenue of $40.4 million. The company projects
full-year earnings of $0.51 to $0.55 per share, versus analysts’ estimates of $0.55 per share.
-
Bunge Ltd (NYSE: BG) dropped 5.7 percent to $71.37 as
the company announced plans to acquire 70 percent ownership interest in IOI Loders Croklaan for $946 million. Baird initiated
coverage on Bunge with a Neutral rating and a $77.00 price target.
-
Brookfield Infrastructure Partners L.P. (NYSE: BIP)
shares fell 5.2 percent to $41.57. Brookfield Infrastructure priced 16.628 million share offering at $42.10 per unit.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.